Is chemoradiation effective or harmful for stage VI gastric cancer patients?

  • Authors:
    • Yoshiro Saikawa
    • Tetsuro Kubota
    • Tsunehiro Takahashi
    • Yukako Akatsu
    • Rieko Nakamura
    • Masashi Yoshida
    • Naoyuki Shigematsu
    • Yoshihide Otani
    • Koichiro Kumai
    • Toshifumi Hibi
    • Masaki Kitajima
  • View Affiliations

  • Published online on: May 1, 2005     https://doi.org/10.3892/or.13.5.865
  • Pages: 865-870
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We aim to clarify beneficial effect of pre-operative radiation with chemotherapy in highly advanced gastric cancer patients, evaluating histological response, toxicity and patients' quality of life (QOL). We used pre-operative radiation with S-1 and low-dose cisplatin to treat 8 patients with highly advanced gastric cancer (clinical stage IV) in a pilot study. Clinical staging after therapy showed 5 PRs (partial response), 2 NCs (no change), and 1 PD (partial disease) following evaluation of the primary tumor and suspicious metastatic lesions in the lymph nodes, esophagus, liver, and peritoneum, for a response rate of 62.5% (5/8 cases). Of 8 patients, 6 underwent surgery, and 2 of these 6 patients had a histologically complete response (grade 3 effect) and 3 patients had a partial response (grade 2 effect), suggesting that a high histological response (5/6 cases; 83.3%) is expected by the chemoradiation. The survival analysis showed that 5 out of the 8 patients died within 10 months after initiating therapy, while 3 patients are alive without recurrence at 15, 18, and 30 months after therapy, suggesting a relatively good outcome for clinical stage IV gastric cancer. All cases showed grade 2-4 bone marrow suppression toxicity and/or grade 0-2 gastro-intestinal toxicity, while 5 out of 8 patients (62.5%) showed improvement in appetite loss at the end of the therapy, indicating that the patients' quality of life (QOL) was preserved. Chemoradiation may be a powerful regimen for obtaining histological response with tolerable toxicity and improved QOL in highly advanced gastric cancer patients.

Related Articles

Journal Cover

May 2005
Volume 13 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Saikawa Y, Kubota T, Takahashi T, Akatsu Y, Nakamura R, Yoshida M, Shigematsu N, Otani Y, Kumai K, Hibi T, Hibi T, et al: Is chemoradiation effective or harmful for stage VI gastric cancer patients?. Oncol Rep 13: 865-870, 2005
APA
Saikawa, Y., Kubota, T., Takahashi, T., Akatsu, Y., Nakamura, R., Yoshida, M. ... Kitajima, M. (2005). Is chemoradiation effective or harmful for stage VI gastric cancer patients?. Oncology Reports, 13, 865-870. https://doi.org/10.3892/or.13.5.865
MLA
Saikawa, Y., Kubota, T., Takahashi, T., Akatsu, Y., Nakamura, R., Yoshida, M., Shigematsu, N., Otani, Y., Kumai, K., Hibi, T., Kitajima, M."Is chemoradiation effective or harmful for stage VI gastric cancer patients?". Oncology Reports 13.5 (2005): 865-870.
Chicago
Saikawa, Y., Kubota, T., Takahashi, T., Akatsu, Y., Nakamura, R., Yoshida, M., Shigematsu, N., Otani, Y., Kumai, K., Hibi, T., Kitajima, M."Is chemoradiation effective or harmful for stage VI gastric cancer patients?". Oncology Reports 13, no. 5 (2005): 865-870. https://doi.org/10.3892/or.13.5.865